BofA/Merrill Lynch Downgrades Dr. Reddy's Laboratories (RDY) to Underperform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. SPOT
6. FIX
7. BE
8. TSCO
9. WCN
10. NDAQ

Go back to BofA/Merrill Lynch Downgrades Dr. Reddy's Laboratories (RDY) to Underperform

Morgan Stanley Downgrades Dr. Reddy's Laboratories (RDY) to Equalweight

May 14, 2014 7:32 AM EDT

Morgan Stanley downgraded Dr. Reddy's Laboratories (NYSE: RDY) from Overweight to Equalweight.

For an analyst ratings summary and ratings history on Dr. Reddy's Laboratories click here. For more ratings news on Dr. Reddy's Laboratories click here.

Shares of Dr. Reddy's Laboratories closed at $43.82 yesterday.

... More

Dr. Reddys Labs (RDY) Reports Q4 EPS of $0.47

May 13, 2014 7:03 AM EDT

Dr. Reddys Labs (NYSE: RDY) reported Q4 EPS of $0.47, versus $0.56 reported last year. Revenue for the quarter came in at $580 million, versus $557 million reported last year.

For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.

... More